Terry Murdock
Geschäftsführer bei G1 THERAPEUTICS, INC.
Vermögen: 400 043 $ am 30.04.2024
Aktive Positionen von Terry Murdock
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Geschäftsführer | 01.01.2019 | - |
| Corporate Officer/Principal | 03.08.2017 | - |
Karriereverlauf von Terry Murdock
Ehemalige bekannte Positionen von Terry Murdock
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | 01.09.2014 | 01.07.2017 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Geschäftsführer | 01.01.2001 | 01.05.2012 |
| The US Oncology Network | Corporate Officer/Principal | 01.01.1995 | 01.01.2001 |
| ERGOMED | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Terry Murdock
| The University of Texas at Austin | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ERGOMED | Commercial Services |
| G1 THERAPEUTICS, INC. | Health Technology |
| IQVIA HOLDINGS INC. | Health Services |
| Private Unternehmen | 2 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| The US Oncology Network |
- Börse
- Insiders
- Terry Murdock
- Erfahrung
